Irafamdastat

N/A

Report date: 2025/06/05 16:57:32
NME

Base Information

Drug NameIrafamdastat
Drug Alias NameCC-97489BMS-986368ABX-1772ABD-115672
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnandamide amidohydrolase inhibitorsMonoglyceride lipase inhibitors
TargetsAnandamide amidohydrolaseMonoglyceride lipase
Therapy Area/IndicationsAgitationAlzheimer DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesCelgene Corp
Inactive CompaniesN/A
Active IndicationsAgitationAlzheimer DiseaseMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A